Cerebral small vessel disease research and family advocacy
Building a clear path from inherited small vessel disease to targeted treatment.
CSVD Therapeutics brings families, clinicians, scientists, and therapy developers together around one urgent goal: accelerating credible treatments for genetic cerebral small vessel diseases while keeping patients at the center of the work.
A platform for CSVD families, clinicians, and scientists working toward gene-targeted therapies.
CSVD Therapeutics focuses on inherited forms of CSVD (cerebral small vessel diseases), especially COL4A1-related and NOTCH3-related disorders (CADASIL), where genetics gives us a precise starting point for therapeutic development.
Start with the leadership team, the COL4A1 and CADASIL projects, or the roadmap for research readiness.
Read more about CSVD Therapeutics
